Details for New Drug Application (NDA): 202077
✉ Email this page to a colleague
The generic ingredient in LATANOPROST is latanoprostene bunod. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the latanoprostene bunod profile page.
Summary for 202077
| Tradename: | LATANOPROST |
| Applicant: | Carnegie |
| Ingredient: | latanoprost |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.005% | ||||
| Approval Date: | Feb 11, 2013 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
